MoleculeMind's New MMDesign Technical Report Demonstrates 94.7% Campaign Success Rate Across Diverse Molecular Targets and Modalities

<p>SHANGHAI, Nov. 3, 2026 /PRNewswire/ -- MoleculeMind, an AI-native biological infrastructure company, recently released a new technical report detailing the performance of MMDesign, its AI-powered de novo molecular design platform which demonstrated a 94.7% campaign success rate across...</p>